---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-011246"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2025-07-15T23:59:59+00:00"
generated_at: "2026-05-18T06:35:32.240263+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health appoints Jane Pine Wood to board effective July 11, 2025

## Summary
- Jane Pine Wood appointed as director, effective July 11, 2025.
- Wood has over 38 years of experience as an attorney for laboratories and healthcare providers.
- She currently serves as Counsel at McDonald Hopkins; previously Chief Legal Counsel at BioReference Health.
- No family relationships or related-party transactions with the company; no arrangement with any person for appointment.

## SEC filing metadata
- accession: 0001493152-25-011246
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2025-07-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000149315225011246/0001493152-25-011246-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000149315225011246/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-011246
- JSON: https://secwatch.observer/filing/0001493152-25-011246.json
- Plain text: https://secwatch.observer/filing/0001493152-25-011246.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.